Serial #90031677
LIVE

Serial Number

90031677

Owner

E&S Healthcare Co., Ltd.

Attorney

Max Vern

Filing Date

Jul 1, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #90031677 Trademark

Serial Number: 90031677 • Registration: 7051427

Serial #90031677 is a trademark filed by E&S Healthcare Co., Ltd. on July 1, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

E&S Healthcare Co., Ltd. (5 trademarks)

42, Gukjegwahak 11-ro,

Entity Type: 98

Trademark Details

Filing Date

July 1, 2020

Registration Date

May 16, 2023

Published for Opposition

February 28, 2023

Goods & Services

Diagnostic reagents for medical use for immune disease; diagnostic reagents for medical use; medical diagnostic reagents; diagnostic reagents for medical or veterinary purposes; immunoassay diagnostic reagents for medical purposes; biological reagents for medical purposes, biological reagents for medical diagnostic purposes; reagents for medical diagnostic purposes for the analysis of body fluids; reagent paper for medical purposes; medicated lozenges; chemical reagents for medical purposes; diagnostic reagents for medicinal use; clinical medical reagents; clinical diagnostic reagents in the nature of clinical medical reagents

Medical device for detecting cancer; medical device, namely, in vitro diagnostic medical device for detecting breast cancer by Thioredoxin 1(Trx1) expression level; medical device for breast cancer detection for medical use, namely breast cancer diagnostic kit comprised of saliva and tissue collection tubes for medical purposes, anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; medical diagnostic apparatus for detecting cancer and testing for viruses; apparatus for blood testing for medical use; medical device and apparatus in the field of clinical diagnosis, namely, a breast cancer diagnostic kit comprised of saliva and tissue collection tubes for medical purposes, anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; testing instruments for medical diagnostic purposes, namely, a breast cancer diagnostic kit comprised of saliva and tissue collection tubes for medical purposes, anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; tools for medical diagnostics, namely, a breast cancer diagnostic kit comprised of saliva and tissue collection tubes for medical purposes, anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; blood analysis apparatus for diagnosis.

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 16, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 16, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 28, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 20, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 20, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 20, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 20, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 20, 2023 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 20, 2022 GNFN
FINAL REFUSAL E-MAILED
Jul 20, 2022 GNFR
FINAL REFUSAL WRITTEN
Jul 20, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2022 CRFA
ASSIGNED TO LIE
Jun 21, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 16, 2022 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 10, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
May 10, 2022 GNSL
SUSPENSION LETTER WRITTEN
May 10, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2022 CRFA
ASSIGNED TO LIE
Apr 18, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 14, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 14, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 14, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 14, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 13, 2021 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 26, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 26, 2021 GNSL
SUSPENSION LETTER WRITTEN
Mar 26, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 13, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 13, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 13, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 30, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2020 NWOS
NEW APPLICATION ENTERED
Jul 4, 2020 NWAP